top
Search terms
Results 1 - 3 of 3 - ordered by :
Epeuropace

Over time many stroke risk stratification schema have been developed, initially with the objective to better define high-risk patients who could be subjected to an inconvenient (and potentially ...

Europace, Editorial, Ron Pisters, Jonas B. Olesen, Gregory Y.H. Lip

Date : 01/01/2012 Item size : 140103 bytes
Epeuropace

Warfarin, the most commonly applied VKA, reduces the stroke risk by 64%.1 The major drawbacks of VKA therapy include the risk of bleeding, especially intracranial haemorrhage, many food and drugdrug ...

Europace, Review, T. Lewalter, P. Kanagaratnam, B. Schmidt, M. Rosenqvist, J. E. Nielsen-Kudsk, R. Ibrahim, B. A. Albers, A. J. Camm

Date : 01/05/2014
Escardio

Boris SCHMIDT (Frankfurt, DE) 14:00 P1180 Stroke reduction by combining catheter ablation and left atrial appendage closure in high risk patients Martin SWAANS (Nieuwegein, NL) 14:00 P1181 Does left ...

Poster session 5: Atrial fibrillation, drugs and tools

Date : 25/06/2013 Item size : 74599 bytes